ASTH icon

Astrana Health

24.90 USD
-0.71
2.77%
At close Jul 11, 4:00 PM EDT
After hours
24.90
+0.00
0.00%
1 day
-2.77%
5 days
-1.58%
1 month
-5.54%
3 months
-24.77%
6 months
-17.77%
Year to date
-22.67%
1 year
-44.67%
5 years
54.37%
10 years
149.00%
 

About: Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Employees: 1,900

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.3% more ownership

Funds ownership: 46.33% [Q4 2024] → 46.63% (+0.3%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

1% less capital invested

Capital invested by funds: $822M [Q4 2024] → $814M (-$8.33M) [Q1 2025]

3% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 59

6% less funds holding

Funds holding: 179 [Q4 2024] → 168 (-11) [Q1 2025]

31% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 32

90% less call options, than puts

Call options by funds: $313K | Put options by funds: $3.2M

Research analyst outlook

We haven’t received any recent analyst ratings for ASTH.

Financial journalist opinion

Based on 5 articles about ASTH published over the past 30 days

Positive
Zacks Investment Research
1 day ago
All You Need to Know About Astrana Health, Inc. (ASTH) Rating Upgrade to Strong Buy
Astrana Health, Inc. (ASTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
All You Need to Know About Astrana Health, Inc. (ASTH) Rating Upgrade to Strong Buy
Neutral
Zacks Investment Research
1 day ago
ASTH or CHE: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Astrana Health, Inc. (ASTH) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
ASTH or CHE: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
1 day ago
Tap These 5 Bargain Stocks With Alluring EV-to-EBITDA Ratio
ASTH, KT, UPBD, NOAH and DXPE stand out with low EV-to-EBITDA ratios and strong 2025 earnings growth forecasts.
Tap These 5 Bargain Stocks With Alluring EV-to-EBITDA Ratio
Positive
Zacks Investment Research
1 day ago
New Strong Buy Stocks for July 10th
ASTH, LGCY, STM, BAYRY and KD have been added to the Zacks Rank #1 (Strong Buy) List on July 10, 2025.
New Strong Buy Stocks for July 10th
Neutral
PRNewsWire
1 week ago
Astrana Health Announces Closing of Prospect Health Acquisition
ALHAMBRA, Calif. , July 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it closed the acquisition of Prospect Health on July 1st, 2025.
Astrana Health Announces Closing of Prospect Health Acquisition
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for June 4th
ASLE, ASTH and MITT have been added to the Zacks Rank #5 (Strong Sell) List on May 4 2025.
New Strong Sell Stocks for June 4th
Neutral
PRNewsWire
1 month ago
Astrana Health Strengthens Leadership Team to Scale AI-Enabled Healthcare Delivery Platform for All
ALHAMBRA, Calif. , June 3, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced several key additions to its senior leadership team.
Astrana Health Strengthens Leadership Team to Scale AI-Enabled Healthcare Delivery Platform for All
Neutral
PRNewsWire
1 month ago
Astrana Health, Inc. to Participate in Upcoming Investor Conference
ALHAMBRA, Calif. , June 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO is participating in the William Blair 2025 Growth Stock Conference, being held in Chicago, from Tuesday, June 3, 2025 to Thursday June 5, 2025 including a presentation at 10:40 am CT on Wednesday, June 4.
Astrana Health, Inc. to Participate in Upcoming Investor Conference
Neutral
Seeking Alpha
2 months ago
Astrana Health, Inc. (ASTH) Q1 2025 Earnings Call Transcript
Astrana Health, Inc. (NASDAQ:ASTH ) Q1 2025 Earnings Conference Call May 8, 2025 5:30 PM ET Company Participants Brandon Sim - President & Chief Executive Officer Chan Basho - Chief Operating & Financial Officer. Conference Call Participants Ryan Daniels - William Blair Michael Ha - Baird Jack Slevin - Jefferies Jailendra Singh - Truist Securities Ryan Langston - TD Cowen Brooks O'Neil - Lake Street Capital Markets David Larsen - BTIG Gene Mannheimer - Freedom Capital Markets Thomas Walsh - Barclays Operator Good day, everyone, and welcome to today's Astrana's Health First Quarter 2025 Earnings Call.
Astrana Health, Inc. (ASTH) Q1 2025 Earnings Call Transcript
Negative
Zacks Investment Research
2 months ago
Astrana Health, Inc. (ASTH) Q1 Earnings and Revenues Lag Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.31 per share a year ago.
Astrana Health, Inc. (ASTH) Q1 Earnings and Revenues Lag Estimates
Charts implemented using Lightweight Charts™